These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26620449)

  • 1. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression.
    Froud R; Bjørkli T; Bright P; Rajendran D; Buchbinder R; Underwood M; Evans D; Eldridge S
    BMC Musculoskelet Disord; 2015 Nov; 16():370. PubMed ID: 26620449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding source, trial outcome and reporting quality: are they related? Results of a pilot study.
    Clifford TJ; Barrowman NJ; Moher D
    BMC Health Serv Res; 2002 Sep; 2(1):18. PubMed ID: 12213183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.
    Saldanha IJ; Scherer RW; Rodriguez-Barraquer I; Jampel HD; Dickersin K
    Trials; 2016 Apr; 17(1):213. PubMed ID: 27113767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified versus standard intention-to-treat reporting: are there differences in methodological quality, sponsorship, and findings in randomized trials? A cross-sectional study.
    Montedori A; Bonacini MI; Casazza G; Luchetta ML; Duca P; Cozzolino F; Abraha I
    Trials; 2011 Feb; 12():58. PubMed ID: 21356072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals.
    Bridoux V; Moutel G; Schwarz L; Michot F; Herve C; Tuech JJ
    World J Surg; 2014 Oct; 38(10):2487-93. PubMed ID: 24824646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of lesser-impact-factor surgical journals as a source of negative and inconclusive outcomes reporting.
    Kanaan Z; Galandiuk S; Abby M; Shannon KV; Dajani D; Hicks N; Rai SN
    Ann Surg; 2011 Mar; 253(3):619-23. PubMed ID: 21270633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of Surgical Randomized Controlled Trials: Part 2. Funding Source, Conflict of Interest, and Sample Size in Plastic Surgery.
    Voineskos SH; Coroneos CJ; Ziolkowski NI; Kaur MN; Banfield L; Meade MO; Chung KC; Thoma A; Bhandari M
    Plast Reconstr Surg; 2016 Feb; 137(2):453e-461e. PubMed ID: 26818335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners' confidence in conclusions, a three-arm randomized controlled trial.
    Buffel du Vaure C; Boutron I; Perrodeau E; Ravaud P
    BMC Med; 2014 Apr; 12():69. PubMed ID: 24779384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.
    Benea C; Turner KA; Roseman M; Bero LA; Lexchin J; Turner EH; Thombs BD
    Syst Rev; 2020 Apr; 9(1):77. PubMed ID: 32268911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-epidemiological study of publication integrity, and quality of conduct and reporting of randomized trials included in a systematic review of low back pain.
    Hayden JA; Ellis J; Ogilvie R; Boulos L; Stanojevic S
    J Clin Epidemiol; 2021 Jun; 134():65-78. PubMed ID: 33545270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timely and complete publication of economic evaluations alongside randomized controlled trials.
    Thorn JC; Noble SM; Hollingworth W
    Pharmacoeconomics; 2013 Jan; 31(1):77-85. PubMed ID: 23329594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small class sizes for improving student achievement in primary and secondary schools: a systematic review.
    Filges T; Sonne-Schmidt CS; Nielsen BCV
    Campbell Syst Rev; 2018; 14(1):1-107. PubMed ID: 37131395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funding source and the quality of reports of chronic wounds trials: 2004 to 2011.
    Hodgson R; Allen R; Broderick E; Bland JM; Dumville JC; Ashby R; Bell-Syer S; Foxlee R; Hall J; Lamb K; Madden M; O'Meara S; Stubbs N; Cullum N
    Trials; 2014 Jan; 15():19. PubMed ID: 24422753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study.
    Lundh A; Barbateskovic M; Hróbjartsson A; Gøtzsche PC
    PLoS Med; 2010 Oct; 7(10):e1000354. PubMed ID: 21048986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry.
    Perlis RH; Perlis CS; Wu Y; Hwang C; Joseph M; Nierenberg AA
    Am J Psychiatry; 2005 Oct; 162(10):1957-60. PubMed ID: 16199844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trials in non-pharmacological rehabilitation research: a scoping review of the reporting of sample size calculation, randomization procedure, and statistical analyses.
    Amiri M; Kumbhare D
    Eur J Phys Rehabil Med; 2020 Dec; 56(6):790-798. PubMed ID: 32935956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.